Project Grant R03NS132074
Award Date
9/7/23
Completion Date
11/30/25
Dollars Obligated
$158K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14260, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $793,535 to Weill Medical College of Cornell University to conduct research on changes in synaptic vesicle-binding of alpha-synuclein as an early biomarker for synucleinopathies like Parkinson's disease and Lewy body dementia. The research aims to identify the gut area with...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is supporting research to identify the origin and pathogenic properties of alpha-synuclein protein strains found in the plasma of individuals with Parkinson's disease (PD). The $231,255 award will allow the Principal Investigator, Dr. George Kannarkat, to: 1) use extracellular...
This $2,192,716 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) aims to understand the role of serine-129 phosphorylation in the aggregation and spreading of α-synuclein pathology associated with Parkinson's disease, dementia with Lewy bodies, and related synucleinopathies. The project leverages novel serine-129 phospho-deficient and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $173,140 to The Regents of the University of California, San Francisco (UCSF) to elucidate the role of neural activity in the degeneration of midbrain dopamine neurons, which is a key pathological process in Parkinson's disease. The project aims to use novel mouse models to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $499,286.59 to the University of Pittsburgh to conduct research on the role of the LRRK2 protein and oxidative stress in the pathogenesis of Parkinson's disease. The research aims to elucidate how wildtype LRRK2 kinase activity is stimulated, where in the cell this occurs, and the...
This Project Grant award, with a total funding amount of $616,200.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The award will support research to investigate the influence of neuromelanin, a pigment found in dopamine neurons, on the degeneration of these neurons in Parkinson's disease. The project will leverage specialized mouse...
This $1,361,977 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research on the role of 14-3-3θ protein phosphorylation in regulating α-synuclein aggregation and vesicular transport. The research team at the University of Alabama at Birmingham will examine how 14-3-3θ phosphorylation at serine 232 impacts its interaction with...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to establish the role of alpha-synuclein-mediated membrane permeabilization in the spread of alpha-synuclein aggregates related to Parkinson's disease and related dementias. The $406,260 award to Purdue University will leverage fluorescence lifetime imaging microscopy...
This Project Grant award of $414,191 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will fund research by Drexel University investigating the relationship between structural variations in alpha-synuclein (α-syn) protein fibrils and the development of distinct neurodegenerative synucleinopathies such as Lewy body dementia, Parkinson's disease, and multiple system atrophy....
This $655,329 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to investigate the role of the GPNMB gene in the pathogenesis of Parkinson's disease, Lewy body dementia, and related synucleinopathies. The research aims to identify the causal genetic variants that regulate GPNMB expression and determine how GPNMB...